Fortress Biotech (FBIO) EBIT (2016 - 2025)
Historic EBIT for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to -$6.8 million.
- Fortress Biotech's EBIT rose 6917.4% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$89.4 million, marking a year-over-year increase of 1567.65%. This contributed to the annual value of -$110.4 million for FY2024, which is 2245.51% up from last year.
- Fortress Biotech's EBIT amounted to -$6.8 million in Q3 2025, which was up 6917.4% from -$36.5 million recorded in Q2 2025.
- In the past 5 years, Fortress Biotech's EBIT ranged from a high of -$6.8 million in Q3 2025 and a low of -$62.0 million during Q4 2021
- In the last 5 years, Fortress Biotech's EBIT had a median value of -$36.6 million in 2024 and averaged -$37.2 million.
- Its EBIT has fluctuated over the past 5 years, first plummeted by 15511.67% in 2021, then skyrocketed by 7288.21% in 2023.
- Quarter analysis of 5 years shows Fortress Biotech's EBIT stood at -$62.0 million in 2021, then grew by 11.88% to -$54.6 million in 2022, then surged by 64.1% to -$19.6 million in 2023, then fell by 21.52% to -$23.8 million in 2024, then skyrocketed by 71.42% to -$6.8 million in 2025.
- Its EBIT stands at -$6.8 million for Q3 2025, versus -$36.5 million for Q2 2025 and -$22.3 million for Q1 2025.